Free Trial

OptimizeRx (OPRX) Earnings Date, Estimates & Call Transcripts

OptimizeRx logo
$5.15
-0.07 (-1.34%)
(As of 11/1/2024 ET)

OptimizeRx Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 13After Market ClosesConfirmed
Actual EPS
(Aug. 8)
-$0.14 Beat By $0.11
Consensus EPS
(Aug. 8)
-$0.25

OptimizeRx posted Q2 2024 earnings on August 8, 2024, reporting an EPS of -$0.14, which topped the consensus estimate of -$0.25 by $0.11. Quarterly revenue was reported to be $18.81 million, below the consensus estimate of $20.47 million. With a trailing EPS of -$1.00, OptimizeRx's earnings are expected to grow next year, from ($0.33) to ($0.28) per share.

OPRX Upcoming Earnings

OptimizeRx's next earnings date is scheduled for Wednesday, November 13, 2024, with a conference call scheduled for at 4:30 PM ET. Interested parties can register for or listen to the call.

Get OptimizeRx Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OptimizeRx and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

OPRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

OPRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

OptimizeRx Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.36-$0.34-$0.35
Q2 20243-$0.26-$0.21-$0.24
Q3 20243-$0.18-$0.04-$0.13
Q4 20243$0.04$0.10$0.07
FY 202411($0.76)($0.49)($0.65)

OptimizeRx Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/13/2024
(Confirmed)
-------  
8/8/2024Q2 2024-$0.25-$0.14+$0.11-$0.06$20.47M$18.81M
5/14/2024Q1 2024-$0.11-$0.27 -$0.16-$0.16$18.66M$19.69M    
4/16/2024Q4 2023-$0.11+$0.11$0.45-$28.37M  
11/6/2023Q3 2023-$0.19-$0.10+$0.09-$0.03$15.07M$16.33M  
8/14/2023Q2 2023-$0.28-$0.21+$0.07-$0.18$14.97M$13.82M      
5/10/2023Q1 2023-$0.32-$0.34 -$0.02-$0.31$12.37M$13.00M  
3/8/2023Q4 2022-$0.01+$0.01$0.04$21.84M$19.70M  
11/8/2022Q3 2022-$0.18-$0.16+$0.02-$0.13$15.16M$15.09M  

OptimizeRx Earnings - Frequently Asked Questions

OptimizeRx has confirmed that its next quarterly earnings data will be published on Wednesday, November 13th, 2024. Learn more on OPRX's earnings history.

OptimizeRx updated its FY 2024 earnings guidance on Thursday, August, 8th. The company issued revenue guidance of $100.0 million-, compared to the consensus revenue estimate of $101.5 million.

In the previous quarter, OptimizeRx (NASDAQ:OPRX) reported ($0.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.25) by $0.11. Learn more on analysts' earnings estimate vs. OPRX's actual earnings.

OptimizeRx (NASDAQ:OPRX) has a recorded annual revenue of $83.20 million.

OptimizeRx (NASDAQ:OPRX) has a recorded net income of -$17.57 million. OPRX has generated -$1.00 earnings per share over the last four quarters.

OptimizeRx's earnings are expected to grow from ($0.33) per share to ($0.28) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:OPRX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners